Related Experiment Video
Updated: Dec 15, 2025

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Mutant FOXL2C134W Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell Tumors
Stine E Weis-Banke1,2, Mads Lerdrup3, Daniela Kleine-Kohlbrecher1,2
1Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen N, Denmark.
Abstract:
The mutant protein FOXL2C134W is expressed in at least 95% of adult-type ovarian granulosa cell tumors (AGCT) and is considered to be a driver of oncogenesis in this disease. However, the molecular mechanism by which FOXL2C134W contributes to tumorigenesis is not known. Here, we show that mutant FOXL2C134W acquires the ability to bind SMAD4, forming a FOXL2C134W/SMAD4/SMAD2/3 complex that binds a novel hybrid DNA motif AGHCAHAA, unique to the FOXL2C134W mutant. This binding induced an enhancer-like chromatin state, leading to transcription of nearby genes, many of which are characteristic of epithelial-to-mesenchymal transition. FOXL2C134W also bound hybrid loci in primary AGCT. Ablation of SMAD4 or SMAD2/3 resulted in strong reduction of FOXL2C134W binding at hybrid sites and decreased expression of associated genes. Accordingly, inhibition of TGFβ mitigated the transcriptional effect of FOXL2C134W. Our results provide mechanistic insight into AGCT pathogenesis, identifying FOXL2C134W and its interaction with SMAD4 as potential therapeutic targets to this condition. SIGNIFICANCE: FOXL2C134W hijacks SMAD4 and leads to the expression of genes involved in EMT, stemness, and oncogenesis in AGCT, making FOXL2C134W and the TGFβ pathway therapeutic targets in this condition. GRAPHICAL ABSTRACT: http://cancerres.aacrjournals.org/content/canres/80/17/3466/F1.large.jpg.
Insights
The FOXL2C134W mutation drives ovarian tumors by hijacking SMAD4, activating genes for epithelial-to-mesenchymal transition. Targeting FOXL2C134W and TGFβ offers new therapeutic strategies for adult-type granulosa cell tumors (AGCT).
Area of Science:
- Molecular Oncology
- Cancer Genomics
- Epigenetics
Background:
- The FOXL2C134W mutant protein is a key driver in over 95% of adult-type ovarian granulosa cell tumors (AGCT).
- The precise molecular mechanisms by which FOXL2C134W promotes tumorigenesis remain largely unknown.
Purpose of the Study:
- To elucidate the molecular mechanism of FOXL2C134W-driven oncogenesis in AGCT.
- To identify potential therapeutic targets based on the identified molecular interactions.
Main Methods:
- Analysis of FOXL2C134W protein interactions with SMAD4 and SMAD2/3.
- Identification of novel DNA binding motifs for the FOXL2C134W/SMAD complex.
- Assessment of chromatin states and gene expression changes upon FOXL2C134W binding.
- Experimental ablation of SMAD4 or SMAD2/3 and inhibition of TGFβ signaling.
Main Results:
- Mutant FOXL2C134W forms a complex with SMAD4/SMAD2/3, binding a unique AGHCAHAA DNA motif.
- This interaction induces an enhancer-like chromatin state, activating genes associated with epithelial-to-mesenchymal transition (EMT).
- SMAD4/SMAD2/3 ablation or TGFβ inhibition significantly reduces FOXL2C134W binding and target gene expression.
Conclusions:
- FOXL2C134W oncogenesis in AGCT involves hijacking the SMAD4 pathway to promote EMT and stemness.
- The FOXL2C134W-SMAD4 interaction and the TGFβ pathway represent promising therapeutic targets for AGCT.
Related Concept Videos
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Hedgehog Signaling Pathway
Canonical Wnt Signaling Pathway
Pleiotropy
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...

